Royalty Pharma Q4 2023 Financial Results Call

Analyst Consensus

The Visible Alpha Consensus Estimates are based on data available on Visible Alpha which have been submitted before the indicated date. Visible Alpha and analysts have had no access to Royalty Pharma’s internal forecasts or information which is not publicly available. Royalty Pharma assumes no obligation to update or revise such information. The Visible Alpha Consensus Estimates are based on the analysts’ opinions, projections and predictions regarding the performance of the underlying product. Royalty Pharma neither endorses, concurs nor accepts responsibility for, any figures presented in the Visible Alpha Consensus Estimates nor does it endorse, concur or accept responsibility whatsoever for the views of Visible Alpha or any other analysts reporting on the underlying products. Royalty Pharma seeks to ensure that the Visible Alpha Consensus Estimates are up-to-date, but it is not under an obligation to update the Visible Alpha Consensus Estimates, revise or supplement the figures to reflect circumstances existing after the date hereof. The Visible Alpha Consensus Estimates are provided purely as a courtesy to shareholders and other stakeholders and for information purposes only. The Visible Alpha Consensus Estimates are not intended to, nor does the Visible Alpha Consensus Estimates, constitute investment advice or any solicitation to buy, hold or sell shares or other securities. No warranty or representation, either express or implied, is made by Royalty Pharma or its affiliates, or their respective directors, officers and employees, in relation to the accuracy, completeness or achievability of the Visible Alpha Consensus Estimates and, to the fullest extent permitted by law, no responsibility or liability is accepted by any of those persons in respect of those matters. Royalty Pharma does not accept any liability whatsoever for reliance upon, or actions taken based on, any of the information set out in the Visible Alpha Consensus Estimates. The Visible Alpha Consensus Estimates are forward-looking and as such are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted. By clicking on the ‘Download’ button below, you confirm that you understand and accept the nature of the information provided by Royalty Pharma on the basis set out above.